First City Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $275K | Hold |
2,175
| – | – | 0.13% | 143 |
|
|
2026
Q1 | $303K | Hold |
2,175
| – | – | 0.16% | 129 |
|
|
2025
Q4 | $267K | Sell |
2,175
-100
| -4% | -$12.2K | 0.14% | 139 |
|
|
2025
Q3 | $253K | Sell |
2,275
-21
| -0.9% | -$2.39K | 0.14% | 137 |
|
|
2025
Q2 | $255K | Hold |
2,296
| – | – | 0.15% | 135 |
|
|
2025
Q1 | $257K | Buy |
2,296
+5
| +0.2% | +$516 | 0.15% | 130 |
|
|
2024
Q4 | $212K | Buy |
+2,291
| New | +$206K | 0.11% | 147 |
|
|
2023
Q2 | – | Sell |
-2,477
| Closed | -$204K | – | 173 |
|
|
2023
Q1 | $204K | Sell |
2,477
-32
| -1% | -$2.65K | 0.12% | 161 |
|
|
2022
Q4 | $215K | Buy |
+2,509
| New | +$199K | 0.13% | 153 |
|
|
2021
Q4 | – | Sell |
-3,027
| Closed | -$211K | – | 170 |
|
|
2021
Q3 | $211K | Sell |
3,027
-200
| -6% | -$14.1K | 0.12% | 161 |
|
|
2021
Q2 | $229K | Hold |
3,227
| – | – | 0.13% | 154 |
|
|
2021
Q1 | $218K | Buy |
+3,227
| New | +$208K | 0.13% | 151 |
|
|
2020
Q4 | – | Sell |
-5,446
| Closed | -$349K | – | 175 |
|
|
2020
Q3 | $349K | Buy |
5,446
+1,902
| +54% | +$132K | 0.13% | 140 |
|
|
2020
Q2 | $273K | Buy |
3,544
+350
| +11% | +$26.8K | 0.21% | 112 |
|
|
2020
Q1 | $239K | Sell |
3,194
-300
| -9% | -$20.7K | 0.23% | 100 |
|
|
2019
Q4 | $227K | Sell |
3,494
-1,733
| -33% | -$113K | 0.16% | 131 |
|
|
2019
Q3 | $331K | Sell |
5,227
-1,500
| -22% | -$98.1K | 0.24% | 107 |
|
|
2019
Q2 | $454K | Buy |
6,727
+100
| +2% | +$6.58K | 0.33% | 91 |
|
|
2019
Q1 | $431K | Sell |
6,627
-1,550
| -19% | -$103K | 0.31% | 94 |
|
|
2018
Q4 | $511K | Sell |
8,177
-2,450
| -23% | -$171K | 0.4% | 78 |
|
|
2018
Q3 | $821K | Buy |
10,627
+1,100
| +12% | +$83.1K | 0.55% | 64 |
|
|
2018
Q2 | $675K | Sell |
9,527
-100
| -1% | -$7.06K | 0.48% | 69 |
|
|
2018
Q1 | $726K | Hold |
9,627
| – | – | 0.54% | 62 |
|
|
2017
Q4 | $690K | Sell |
9,627
-1,050
| -10% | -$79.7K | 0.47% | 68 |
|
|
2017
Q3 | $865K | Sell |
10,677
-150
| -1% | -$11.5K | 0.6% | 57 |
|
|
2017
Q2 | $766K | Sell |
10,827
-155
| -1% | -$10.3K | 0.56% | 62 |
|
|
2017
Q1 | $746K | Buy |
10,982
+52
| +0.5% | +$3.66K | 0.55% | 62 |
|
|
2016
Q4 | $783K | Buy |
+10,930
| New | +$812K | 0.59% | 58 |
|
|
2015
Q4 | – | Sell |
-3,395
| Closed | -$333K | – | 674 |
|
|
2015
Q3 | $333K | Buy |
+3,395
| New | +$377K | 0.25% | 101 |
|
|
2015
Q2 | – | Sell |
-2,745
| Closed | -$269K | – | 620 |
|
|
2015
Q1 | $269K | Buy |
2,745
+70
| +3% | +$7.11K | 0.19% | 111 |
|
|
2014
Q4 | $252K | Hold |
2,675
| – | – | 0.17% | 119 |
|
|
2014
Q3 | $285K | Sell |
2,675
-300
| -10% | -$29.4K | 0.2% | 115 |
|
|
2014
Q2 | $247K | Buy |
+2,975
| New | +$232K | 0.18% | 122 |
|
|
2014
Q1 | – | Sell |
-2,975
| Closed | -$223K | – | 627 |
|
|
2013
Q4 | $223K | Buy |
+2,975
| New | +$207K | 0.18% | 135 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
First City Capital Management's GILD Position: Q2 2026 in Review
First City Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,175 shares worth $275K. The position accounts for 0.13% of the portfolio, ranked #143.
First City Capital Management first reported a position in GILD in Q4 2013 and has held it in 34 quarters since. The position peaked at $865K in Q3 2017. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- First City Capital Management held 2,175 shares of Gilead Sciences worth $275K as of Q2 2026.
- First City Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.13% of First City Capital Management's portfolio in Q2 2026, its #143 holding.
- First City Capital Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 34 quarters since.
- First City Capital Management's Gilead Sciences position peaked at $865K in Q3 2017.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on First City Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.